Synthesis and discovery of biologically active cell-permeable cyclic peptides
生物活性细胞渗透性环肽的合成和发现
基本信息
- 批准号:7898759
- 负责人:
- 金额:$ 30.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-29 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAffinityAgeAmidesAntibioticsAntifungal AgentsAntifungal AntibioticsBacteriaBiochemicalBiologicalBiological AssayBiological FactorsBiological ProcessCell Membrane PermeabilityCellsCharacteristicsChemical ModelsCollectionCyclic PeptidesDevelopmentDiffusionExhibitsGenerationsHydrogenLeadLearningLibrariesLigandsLipid BilayersMammalian CellMembraneMethodsMethylationModificationMolecularMolecular ConformationNutsOrganic ChemistryParentsPeptidesPermeabilityPhenotypeProdrugsRelative (related person)ResearchSideTestingTimeVertebral columnVibrio choleraeYeastsbasedrug developmenthigh throughput screeningimprovednovel strategiesprogramspublic health relevancescaffoldsmall molecule
项目摘要
DESCRIPTION (provided by applicant): Cyclic peptides have been explored as ligands against a wide variety of biological targets. They are relatively easy to synthesize, and, at the same time, exhibit a degree of complexity unrivaled by most other classes of small molecules. However, cyclic peptides often suffer from poor cell permeability, a characteristic common to peptides in general. Indeed, a key bottleneck in drug development lies in the inability to predict and control factors that govern cell permeability in small molecules. The global objective of our research program is to create a new generation of biologically active, cell permeable cyclic peptides as probes and lead antibiotic and antifungal compounds. In this proposal, we seek to broaden our understanding of membrane permeability in this important class of compounds by testing hypotheses regarding the influence on backbone conformation, ring size, and side chain functionality, on the passive membrane diffusion of cyclic peptides. Taking a lesson from natural products, cell permeability in cyclic peptides is often determined by key modification - namely, N-methylation of one or more peptide amides - that help to transport the polar backbone across the hydrophobic lipid bilayer. Here we apply a powerful new approach to regioselective N-methylation to generate libraries of cyclic peptides that exhibit improved membrane permeability over their non-methylated counterparts. In addition, we will develop a strategy for the sulfenylation of cyclic and linear peptides, generating bioreversible prodrugs with greatly improved membrane permeability relative to their unmodified parent compounds. Finally, we have put in place a panel of high-throughput phenotypic screens in yeast, bacteria (V. cholera), and mammalian cells for compounds that modulate a wide variety of biological processes. Using the methods developed in the first three aims, we will generate libraries of natural product-inspired, membrane permeable cyclic peptides for input into these screens, with the end result being a collection of potent bioactive compounds poised for further development.
PUBLIC HEALTH RELEVANCE: The overall objective of our research program is to understand the structural basis of membrane permeability in small molecules. We propose to use cyclic peptides as molecular scaffolds to study the conformational basis of permeability, and apply what we learn to create a new generation of biochemical probes. We combine computational approaches with synthetic organic chemistry and high-throughput screening to develop a new class of bioactive cyclic peptides inspired by natural products. We expect that new antibiotics and antifungal agents will emerge from this project.
描述(由申请人提供):已探索环肽作为针对多种生物靶标的配体。它们相对容易合成,同时表现出大多数其他类别的小分子无法比拟的复杂程度。然而,环肽通常具有差的细胞渗透性,这是一般肽的共同特征。事实上,药物开发的一个关键瓶颈在于无法预测和控制控制小分子细胞渗透性的因素。我们的研究计划的全球目标是创造新一代的生物活性,细胞可渗透的环肽作为探针和领先的抗生素和抗真菌化合物。 在这个建议中,我们试图扩大我们的理解膜渗透性在这一类重要的化合物通过测试假设的影响骨架构象,环的大小,侧链的功能,对被动膜扩散的环肽。从天然产物中吸取教训,环肽的细胞渗透性通常由关键修饰决定-即一个或多个肽酰胺的N-甲基化-这有助于将极性骨架运输穿过疏水脂质双层。 在这里,我们采用了一种强大的新方法,区域选择性N-甲基化,以产生图书馆的环肽,表现出改善膜渗透性超过其非甲基化的同行。此外,我们将开发一种策略,用于环状和线性肽的磺酰化,产生生物可逆的前药,相对于其未修饰的母体化合物,其膜渗透性大大提高。最后,我们已经在酵母,细菌(霍乱弧菌)和哺乳动物细胞中建立了一个高通量表型筛选小组,用于调节各种生物过程的化合物。 使用前三个目标中开发的方法,我们将生成天然产物启发的膜渗透性环肽库,用于输入这些筛选,最终结果是一系列潜在的生物活性化合物,准备进一步开发。
公共卫生相关性:我们研究计划的总体目标是了解小分子膜渗透性的结构基础。我们建议使用环肽作为分子支架来研究渗透性的构象基础,并应用我们所了解的来创建新一代的生化探针。我们将联合收割机计算方法与合成有机化学和高通量筛选相结合,开发出一类受天然产物启发的新型生物活性环肽。我们希望新的抗生素和抗真菌剂将从这个项目中出现。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert SCOTT LOKEY其他文献
Robert SCOTT LOKEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert SCOTT LOKEY', 18)}}的其他基金
Advancing the basic science of membrane permeability in macrocyclic peptides
推进大环肽膜渗透性的基础科学
- 批准号:
10552484 - 财政年份:2023
- 资助金额:
$ 30.82万 - 项目类别:
Upgrade of core imaging instrumentation and robotics for the UCSC Chemical Screening Center
UCSC 化学筛查中心核心成像仪器和机器人升级
- 批准号:
10177241 - 财政年份:2021
- 资助金额:
$ 30.82万 - 项目类别:
Synthesis and discovery of biologically active cell-permeable cyclic peptides
生物活性细胞渗透性环肽的合成和发现
- 批准号:
8008958 - 财政年份:2010
- 资助金额:
$ 30.82万 - 项目类别:
NCRR: UCSC Integrated Small Molecule Screening Facility
NCRR:UCSC 集成小分子筛选设施
- 批准号:
7221719 - 财政年份:2007
- 资助金额:
$ 30.82万 - 项目类别:
Small Molecule Modulators of the Actin Cytoskeleton
肌动蛋白细胞骨架的小分子调节剂
- 批准号:
7268781 - 财政年份:2003
- 资助金额:
$ 30.82万 - 项目类别:
Small Molecule Modulators of the Actin Cytoskeleton
肌动蛋白细胞骨架的小分子调节剂
- 批准号:
6707157 - 财政年份:2003
- 资助金额:
$ 30.82万 - 项目类别:
Small Molecule Modulators of the Actin Cytoskeleton
肌动蛋白细胞骨架的小分子调节剂
- 批准号:
7115942 - 财政年份:2003
- 资助金额:
$ 30.82万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 30.82万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 30.82万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 30.82万 - 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 30.82万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 30.82万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 30.82万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 30.82万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 30.82万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 30.82万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 30.82万 - 项目类别:
Continuing Grant